Literature DB >> 29279287

Histone modifiers: Dynamic regulators of the cutaneous transcriptome.

Kanad Ghosh1, Kyle O'Neil1, Brian C Capell2.   

Abstract

By regulating the accessibility of the genome, epigenetic regulators such as histone proteins and the chromatin-modifying enzymes that act upon them control gene expression. Proper regulation of this "histone code" allows for the precise control of transcriptional networks that are essential for establishing and maintaining cell fate and identity, disruption of which may drive carcinogenesis. How these dynamic epigenetic regulators contribute to both skin homeostasis and disease is only beginning to be understood. Here we provide an update of the current understanding of histone modifiers in the skin. Indeed, as one of the most innovative and rapidly expanding areas in all of medicine, it is clear that epigenome-targeting therapies hold great promise for the treatment of dermatological diseases in the coming years.
Copyright © 2017 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chromatin; Epidermal differentiation; Epigenetics; HDACs; Histone modification; Skin cancer; Wound healing

Mesh:

Substances:

Year:  2017        PMID: 29279287      PMCID: PMC5828874          DOI: 10.1016/j.jdermsci.2017.12.006

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  61 in total

Review 1.  HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.

Authors:  X-J Yang; E Seto
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

2.  Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3.

Authors:  George L Sen; Daniel E Webster; Deborah I Barragan; Howard Y Chang; Paul A Khavari
Journal:  Genes Dev       Date:  2008-07-15       Impact factor: 11.361

3.  A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Authors:  Alexander Roesch; Mizuho Fukunaga-Kalabis; Elizabeth C Schmidt; Susan E Zabierowski; Patricia A Brafford; Adina Vultur; Devraj Basu; Phyllis Gimotty; Thomas Vogt; Meenhard Herlyn
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

4.  The transcriptional coactivators p300 and CBP are histone acetyltransferases.

Authors:  V V Ogryzko; R L Schiltz; V Russanova; B H Howard; Y Nakatani
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

5.  Chromatin organization is a major influence on regional mutation rates in human cancer cells.

Authors:  Benjamin Schuster-Böckler; Ben Lehner
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

6.  Mammalian SIRT2 inhibits keratin 19 expression and is a tumor suppressor in skin.

Authors:  Mei Ming; Lei Qiang; Baozhong Zhao; Yu-Ying He
Journal:  Exp Dermatol       Date:  2014-03       Impact factor: 3.960

7.  Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells.

Authors:  Elena Ezhkova; H Amalia Pasolli; Joel S Parker; Nicole Stokes; I-hsin Su; Gregory Hannon; Alexander Tarakhovsky; Elaine Fuchs
Journal:  Cell       Date:  2009-03-20       Impact factor: 41.582

8.  GRHL3/GET1 and trithorax group members collaborate to activate the epidermal progenitor differentiation program.

Authors:  Amelia Soto Hopkin; William Gordon; Rachel Herndon Klein; Francisco Espitia; Kenneth Daily; Michael Zeller; Pierre Baldi; Bogi Andersen
Journal:  PLoS Genet       Date:  2012-07-19       Impact factor: 5.917

9.  Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth.

Authors:  Anthony M Barsotti; Michael Ryskin; Wenyan Zhong; Wei-Guo Zhang; Andreas Giannakou; Christine Loreth; Veronica Diesl; Maximillian Follettie; Jonathon Golas; Michelle Lee; Timothy Nichols; Conglin Fan; Gang Li; Stephen Dann; Valeria R Fantin; Kim Arndt; Dominique Verhelle; Robert A Rollins
Journal:  Oncotarget       Date:  2015-02-20

10.  KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway.

Authors:  Changlin Zhang; Chen Song; Tianze Liu; Ranran Tang; Miao Chen; Fan Gao; Binyi Xiao; Ge Qin; Fen Shi; Wenbin Li; Yixin Li; Xiaoyan Fu; Dingbo Shi; Xiangsheng Xiao; Lan Kang; Wenlin Huang; Xiaojun Wu; Bing Tang; Wuguo Deng
Journal:  Cell Death Dis       Date:  2017-07-20       Impact factor: 8.469

View more
  4 in total

Review 1.  Epigenetic control in skin development, homeostasis and injury repair.

Authors:  Sangjo Kang; Gopal Chovatiya; Tudorita Tumbar
Journal:  Exp Dermatol       Date:  2019-02-12       Impact factor: 3.960

2.  FRA1:c-JUN:HDAC1 complex down-regulates filaggrin expression upon TNFα and IFNγ stimulation in keratinocytes.

Authors:  Sung Shin Ahn; Hyunjin Yeo; Euitaek Jung; Yoongho Lim; Young Han Lee; Soon Young Shin
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-06       Impact factor: 12.779

3.  Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma.

Authors:  Hui Guo; Dongfeng Zeng; Hui Zhang; Taylor Bell; Jun Yao; Yang Liu; Shengjian Huang; Carrie J Li; Elizabeth Lorence; Shouhao Zhou; Tiejun Gong; Changying Jiang; Makhdum Ahmed; Yixin Yao; Krystle J Nomie; Liang Zhang; Michael Wang
Journal:  Oncogene       Date:  2018-10-25       Impact factor: 9.867

Review 4.  Diacylglycerol Kinase Alpha in Radiation-Induced Fibrosis: Potential as a Predictive Marker or Therapeutic Target.

Authors:  Chun-Shan Liu; Peter Schmezer; Odilia Popanda
Journal:  Front Oncol       Date:  2020-05-12       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.